Concepedia

Zhendong Chen

ZC

Statistics

Publications

24

Citations

3K

H-Index

17

Active since

2010

Affiliations

Anhui Medical University(Current)

Second Affiliated Hospital of Anhui Medical University

Henan Cancer Hospital

Sun Yat-sen University

Harbin Medical University

Zhendong Chen is an author at Anhui Medical University specializing in oncology, medicine, and pharmacology.

ORCID

Publications per year

2010–2025

24

Publications

24

Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Jin Lü, Yuxian Bai, Teng Mao et al. · JAMA · 2021 · 801 citations · Full text

, , +17

Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial

Shukui Qin, Zhenggang Ren, Zhiqiang Meng et al. · The Lancet Oncology · 2020 · 638 citations

, , +9

Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study

Jing Huang, Jianming Xu, Yun Chen et al. · The Lancet Oncology · 2020 · 584 citations

, , +14

Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial

Shukui Qin, Feng Bi, Shanzhi Gu et al. · Journal of Clinical Oncology · 2021 · 414 citations · Full text

, , +14

Camrelizumab in combination with apatinib in second-line or above therapy for advanced primary liver cancer: cohort A report in a multicenter phase Ib/II trial

Kuimin Mei, Shukui Qin, Zhendong Chen et al. · Journal for ImmunoTherapy of Cancer · 2021 · 72 citations · Full text

, , +17

1–5 of 24